Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solabegron in Women with Overactive Bladder
NCT00343486Phase 2Completed
- Sponsor
- GSK
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 2 trial of Solabegron in overactive bladder (OAB), sponsored by GSK. Started May 2006; status: completed.
02
Drugs
Solabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00343486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00343486.